Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Acta Oncol. 2019 Mar;58(3):385-387. doi: 10.1080/0284186X.2019.1566771. Epub 2019 Feb 23.

¹ a Department of Oncology , Østfold Hospital Trust , Kalnes , Norway.
² b Department of internal medicine, Vestre Viken, Bærum Hospital , Gjettum , Norway.
³ c Førde Central Hospital , Førde , Norway.
⁴ d Department of Internal Medicine , Vestre Viken, Ringerike Hospital , Hønefoss , Norway.
⁵ e Department of Oncology , Haukeland University Hospital , Bergen , Norway.
⁶ f Institute of Medical Biology, UiT The Arctic University of Norway , Tromsø , Norway.
⁷ g Department of Oncology , University Hospital of North Norway , Tromsø , Norway.
⁸ h Department of Oncology , Odense University Hospital, Institute of Clinical Research, University of Southern Denmark , Odense , Denmark.

No abstract available

Publication types